CSIMarket
 
Dyne Therapeutics Inc   (NASDAQ: DYN)
 

Dyne Therapeutics Inc's Suppliers Performance

DYN's Supply Chain




 
DYN Costs vs Sales of Suppliers Growth Dyne Therapeutics Inc recorded an increase in cost of sales by 68.51 % year on year, sequentially cost of sales grew by 5.4 % in Q2.

More on DYN Suppliers



Dyne Therapeutics Inc recorded increase in cost of sales by 68.51 % year on year, sequentially cost of sales grew by 5.4 % in Q2.

More on DYN Suppliers




Dyne Therapeutics Inc's Comment on Supply Chain


The company depends on third-party manufacturers and single-source suppliers for components including Fab, linkers, and payloads used in its product candidates. This reliance presents risks such as supply disruptions, price increases, delayed deliveries, and potential setbacks in clinical trials and commercialization. Replacing suppliers necessitates regulatory qualification processes, such as BLA supplements, which may result in additional delays and increased costs. Limited alternative sources exist for these components, and establishing new suppliers that comply with regulatory standards can be time-consuming and challenging. Any interruption or failure by these suppliers could adversely affect the company's business and financial condition.

Dyne Therapeutics Inc's Comment on Supply Chain


The company depends on third-party manufacturers and single-source suppliers for components including Fab, linkers, and payloads used in its product candidates. This reliance presents risks such as supply disruptions, price increases, delayed deliveries, and potential setbacks in clinical trials and commercialization. Replacing suppliers necessitates regulatory qualification processes, such as BLA supplements, which may result in additional delays and increased costs. Limited alternative sources exist for these components, and establishing new suppliers that comply with regulatory standards can be time-consuming and challenging. Any interruption or failure by these suppliers could adversely affect the company's business and financial condition.







DYN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Dyne Therapeutics Inc 2,685.28 0.00 -519.41 258
SUBTOTAL 0.00 0.00 0.00 -


Sources: Dyne Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Dyne Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.